191 related articles for article (PubMed ID: 24656088)
41. The role of TLR4 in pathophysiology of antiphospholipid syndrome-associated thrombosis and pregnancy morbidity.
Xie H; Sheng L; Zhou H; Yan J
Br J Haematol; 2014 Jan; 164(2):165-76. PubMed ID: 24180619
[TBL] [Abstract][Full Text] [Related]
42. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
43. Updating on the pathogenic mechanisms 5 of the antiphospholipid antibodies-associated pregnancy loss.
Meroni PL; Gerosa M; Raschi E; Scurati S; Grossi C; Borghi MO
Clin Rev Allergy Immunol; 2008 Jun; 34(3):332-7. PubMed ID: 18175073
[TBL] [Abstract][Full Text] [Related]
44. Domain I: the hidden face of antiphospholipid syndrome.
Pericleous C; Rahman A
Lupus; 2014 Oct; 23(12):1320-3. PubMed ID: 25228738
[TBL] [Abstract][Full Text] [Related]
45. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
[TBL] [Abstract][Full Text] [Related]
46. Prevention & treatment of obstetrical complications in APS: Is hydroxychloroquine the Holy Grail we are looking for?
Meroni PL
J Autoimmun; 2016 Dec; 75():1-5. PubMed ID: 27496152
[TBL] [Abstract][Full Text] [Related]
47. Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expression.
Wu XX; Guller S; Rand JH
Am J Obstet Gynecol; 2011 Dec; 205(6):576.e7-14. PubMed ID: 21871597
[TBL] [Abstract][Full Text] [Related]
48. Clinical relevance of β₂-glycoprotein-I plasma levels in antiphospholipid syndrome (APS).
Banzato A; Pengo V
Curr Rheumatol Rep; 2014 Jun; 16(6):424. PubMed ID: 24797512
[TBL] [Abstract][Full Text] [Related]
49. Effects of anti-β2-GPI antibodies on cytokine production in normal first-trimester trophoblast cells.
Azuma H; Yamamoto T; Chishima F
J Obstet Gynaecol Res; 2016 Jul; 42(7):769-75. PubMed ID: 27098191
[TBL] [Abstract][Full Text] [Related]
50. Complement activation in patients with isolated antiphospholipid antibodies or primary antiphospholipid syndrome.
Breen KA; Seed P; Parmar K; Moore GW; Stuart-Smith SE; Hunt BJ
Thromb Haemost; 2012 Mar; 107(3):423-9. PubMed ID: 22234447
[TBL] [Abstract][Full Text] [Related]
51. MTA3 regulates CGB5 and Snail genes in trophoblast.
Chen Y; Miyazaki J; Nishizawa H; Kurahashi H; Leach R; Wang K
Biochem Biophys Res Commun; 2013 Apr; 433(4):379-84. PubMed ID: 23510993
[TBL] [Abstract][Full Text] [Related]
52. Current clinical and laboratory practice for the investigation of the antiphospholipid syndrome: findings from the 2008 Australasian antiphospholipid antibody survey.
Favaloro EJ; Wong RC
Pathology; 2009; 41(7):666-75. PubMed ID: 20001347
[TBL] [Abstract][Full Text] [Related]
53. Trypanosoma cruzi induces trophoblast differentiation: a potential local antiparasitic mechanism of the human placenta?
Liempi A; Castillo C; Duaso J; Droguett D; Sandoval A; Barahona K; Hernández A; Galanti N; Maya JD; Kemmerling U
Placenta; 2014 Dec; 35(12):1035-42. PubMed ID: 25315217
[TBL] [Abstract][Full Text] [Related]
54. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
55. Effects of Anti-β2-Glycoprotein I Antibody on the Expression of Toll-like Receptors mRNA in Choriocarcinoma and Primary Trophoblast Cells.
Nakamura A; Yamamoto T; Chishima F
J Reprod Med; 2016 Sep; 61(9-10):503-509. PubMed ID: 30383952
[TBL] [Abstract][Full Text] [Related]
56. Alarmin HMGB1 and Soluble RAGE as New Tools to Evaluate the Risk Stratification in Patients With the Antiphospholipid Syndrome.
Manganelli V; Truglia S; Capozzi A; Alessandri C; Riitano G; Spinelli FR; Ceccarelli F; Mancuso S; Garofalo T; Longo A; Valesini G; Sorice M; Conti F; Misasi R
Front Immunol; 2019; 10():460. PubMed ID: 30923525
[TBL] [Abstract][Full Text] [Related]
57. The efficacy of specific IVIG anti-idiotypic antibodies in antiphospholipid syndrome (APS): trophoblast invasiveness and APS animal model.
Blank M; Anafi L; Zandman-Goddard G; Krause I; Goldman S; Shalev E; Cervera R; Font J; Fridkin M; Thiesen HJ; Shoenfeld Y
Int Immunol; 2007 Jul; 19(7):857-65. PubMed ID: 17576752
[TBL] [Abstract][Full Text] [Related]
58. The antiphospholipid syndrome: still an enigma.
Chaturvedi S; McCrae KR
Hematology Am Soc Hematol Educ Program; 2015; 2015():53-60. PubMed ID: 26637701
[TBL] [Abstract][Full Text] [Related]
59. Low molecular weight heparin and aspirin exacerbate human endometrial endothelial cell responses to antiphospholipid antibodies.
Quao ZC; Tong M; Bryce E; Guller S; Chamley LW; Abrahams VM
Am J Reprod Immunol; 2018 Jan; 79(1):. PubMed ID: 29135051
[TBL] [Abstract][Full Text] [Related]
60. Multiple antiphospholipid antibodies positivity and antiphospholipid syndrome criteria re-evaluation.
Forastiero R
Lupus; 2014 Oct; 23(12):1252-4. PubMed ID: 25228718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
